Detalhe da pesquisa
1.
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing.
Cell
; 173(4): 879-893.e13, 2018 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29681456
2.
Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction.
Proc Natl Acad Sci U S A
; 120(1): e2209856120, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574653
3.
Clinically relevant gene signatures provide independent prognostic information in older breast cancer patients.
Breast Cancer Res
; 26(1): 38, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38454481
4.
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer.
Breast Cancer Res
; 26(1): 24, 2024 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321542
5.
Identification of a Notch transcriptomic signature for breast cancer.
Breast Cancer Res
; 26(1): 4, 2024 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172915
6.
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial.
Breast Cancer Res Treat
; 204(2): 299-308, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175448
7.
Pembrolizumab for Early Triple-Negative Breast Cancer.
N Engl J Med
; 382(9): 810-821, 2020 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101663
8.
Women with short survival after diagnosis of metastatic breast cancer: a population-based registry study.
Breast Cancer Res Treat
; 194(1): 49-56, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461374
9.
Axillary evaluation in ductal cancer in situ of the breast: challenging the diagnostic accuracy of clinical practice guidelines.
Br J Surg
; 108(9): 1120-1125, 2021 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34089583
10.
Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer: Results from the phase 3 PANTHER trial.
Cancer
; 126(6): 1175-1182, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31851385
11.
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Br J Cancer
; 122(7): 1119, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31949268
12.
Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer Trial.
Oncologist
; 25(1): 23-32, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31391297
13.
Chemotherapy use near the end-of-life in patients with metastatic breast cancer.
Breast Cancer Res Treat
; 181(3): 645-651, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383058
14.
Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer.
Breast Cancer Res Treat
; 181(1): 87-96, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32232698
15.
Efficacy and safety of cyclin dependent kinases 4/6 inhibitors in the treatment of metastatic breast cancer: a real-world experience.
Acta Oncol
; 59(11): 1382-1387, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32783667
16.
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.
Acta Oncol
; 59(1): 75-81, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31583943
17.
Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production.
Proc Natl Acad Sci U S A
; 114(45): E9635-E9644, 2017 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29078273
18.
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours.
Breast Cancer Res
; 21(1): 34, 2019 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30819233
19.
Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Br J Cancer
; 120(10): 959-967, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30967649
20.
Immune gene expression and response to chemotherapy in advanced breast cancer.
Br J Cancer
; 118(4): 480-488, 2018 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370583